GFH018, a small molecular inhibitor targeting TGF-beta RI kinase, in patients with advanced solid tumors: Final results of the phase I study.
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)